Statute Details
- Title: Goods and Services Tax (Imports Relief) Order
- Act Code: GSTA1993-OR3
- Legislation Type: Subsidiary legislation (SL)
- Authorising Act: Goods and Services Tax Act (Cap. 117A), specifically sections 24(1), (2) and (3) and 86(1)
- Current Version: Current version as at 27 March 2026
- Key Provisions: Section 2 (definitions); Section 3 (certificates/permits to be produced); Section 4 (relief granted and conditions); Section 5 (determination of value for avoidance of doubt)
- Schedule: Lists (i) eligible organisations/persons, (ii) goods eligible for GST import relief, (iii) conditions, and (iv) documents/certificates/permits required
- Notable Amendments (selected): Amended by S 506/2020 (w.e.f. 1 July 2020); S 953/2021 (w.e.f. 16 Dec 2021); S 600/2021 (w.e.f. 13 Aug 2021); S 213/2025 (w.e.f. 1 Apr 2025)
What Is This Legislation About?
The Goods and Services Tax (Imports Relief) Order (“Imports Relief Order”) is a Singapore subsidiary instrument that creates targeted relief from the payment of Goods and Services Tax (GST) when certain goods are imported into Singapore. In practical terms, it operates as a “permission framework” for GST exemption/relief at the point of importation, but only for specific categories of importers and specific categories of goods listed in its Schedule.
The Order is not a general GST exemption regime. Instead, it is a controlled mechanism: relief is granted only to the organisations or persons specified in the Schedule, for the goods specified in the Schedule, and subject to conditions and documentary requirements also set out in the Schedule. The Director-General of Customs (or the relevant customs authority) retains discretion to require security, to impose additional revenue-protection conditions, and in some cases to waive documentary requirements.
For lawyers advising importers, charities, research institutions, healthcare-related entities, or other regulated organisations, the key value of this Order is that it clarifies (i) who can claim relief, (ii) what must be produced at customs clearance, (iii) what conditions must be satisfied, and (iv) how the “value” of imported goods is treated when determining the GST impact—particularly where exempt imports exist alongside the relevant goods.
What Are the Key Provisions?
Section 2 (Definitions): Section 2 sets out definitions used across the Order. While many definitions are standard customs concepts (such as “customs office”, “customs station”, and “proper officer of customs”), the Order also includes definitions that reflect the regulated nature of certain goods and activities that may qualify for relief. For example, the Order defines “medicinal product” by reference to the Medicines Act, and “therapeutic product” by reference to the Health Products Act. It also defines “regulated clinical trial” and “protocol” by reference to the Medicines (Clinical Trials) Regulations 2016 and the Health Products (Clinical Trials) Regulations 2016.
From a practitioner’s perspective, these cross-references matter because eligibility for relief may depend on whether the imported goods fall within a regulated healthcare category (e.g., medicinal or therapeutic products) and whether the importation is connected to a regulated clinical trial. When advising clients, counsel should therefore read the Schedule alongside these definitions to determine whether the goods and the purpose of importation align with the regulatory framework.
Section 3 (Certificates to be produced): Section 3 provides a procedural requirement: any certificate or permit required by the Order must be produced to the proper officer of customs at the time of customs clearance of the goods. This is a strict timing rule. Even if an importer ultimately satisfies substantive conditions, failure to produce the required documents at clearance may jeopardise the relief claim.
Practically, this means importers should implement compliance workflows that ensure the correct permits/certificates are available in time for clearance, and that customs submissions match the documentary requirements specified in the Schedule (including the “form and manner” determined by the Director-General).
Section 4 (Relief granted): Section 4 is the core operative provision. Under Section 4(1), the organisations or persons specified in the second column of the Schedule are granted relief from the payment of GST on the importation of goods specified in the third column. However, the relief is expressly “subject to” multiple layers of conditions:
- Conditions in the fourth column: The Schedule’s conditions must be satisfied.
- Submission of specified documents/certificates/permits: The importer must submit the document, certificate or permit specified in the fifth column, in the form and manner the Director-General may determine.
- Security: The importer must furnish security in such amount as the Director-General may require.
- Further conditions for revenue protection: The Director-General may impose additional conditions.
Section 4(2) adds an important discretion: the Director-General may waive the requirement for a document/certificate/permit submission under Section 4(1)(b) if he considers it expedient. This is a relief mechanism for administrative practicality, but it is discretionary and not automatic. Lawyers should consider whether a waiver is realistically obtainable (e.g., where documents are unavailable due to timing, or where alternative verification is possible), and should advise clients to seek clarity early rather than assume waiver will be granted.
Section 5 (Determination of value of goods): Section 5 addresses a technical but potentially high-impact issue: when determining the value of goods imported into Singapore for the purpose of any item in the Schedule, the value determination must ignore the value of any goods whose import is an exempt import.
In other words, if an importer is dealing with a mix of goods—some exempt and some potentially eligible for relief under the Schedule—Section 5 prevents the exempt goods’ value from being taken into account when calculating the value relevant to the Schedule item. This “for the avoidance of doubt” language is designed to reduce disputes and ensure that the GST relief framework is applied cleanly without cross-contamination from exempt imports.
For practitioners, this provision is particularly relevant in valuation disputes, mixed consignments, and cases where customs valuation and GST base calculations are contested. Counsel should ensure that the importer’s accounting and customs declarations align with the valuation approach mandated by Section 5.
How Is This Legislation Structured?
The Imports Relief Order is structured in a straightforward hierarchy:
(1) Sections: The Order contains a small number of sections—primarily definitions (Section 2), procedural document production (Section 3), the relief grant mechanism (Section 4), and the valuation clarification (Section 5).
(2) The Schedule: The Schedule is the practical “engine” of the relief. It lists, in tabular form, the eligible organisations/persons, the goods eligible for relief, the conditions that must be met, and the documents/certificates/permits required. Because the operative relief in Section 4 is expressly tied to the Schedule columns, the Schedule should be treated as essential reading rather than ancillary material.
(3) Cross-references: Section 2’s definitions cross-reference other regulatory instruments (notably the Customs Act, Medicines Act, and Health Products Act and their clinical trial regulations). These cross-references ensure that the relief regime is aligned with Singapore’s broader regulatory architecture for customs and healthcare products.
Who Does This Legislation Apply To?
The Order applies to the “organisations or persons” specified in the Schedule. It is therefore not a universal exemption for all importers. Eligibility is conditional on both (i) the importer’s identity (as listed in the Schedule) and (ii) the specific goods imported (as listed in the Schedule).
In addition, the Order applies to importations where the importer seeks to rely on the relief mechanism. Even eligible organisations/persons must comply with the procedural and substantive requirements: producing required certificates/permits at customs clearance (Section 3), satisfying the Schedule’s conditions, submitting documents in the required form and manner, and furnishing security if required (Section 4). The Director-General’s ability to impose further revenue-protection conditions means that compliance is not purely mechanical; it is also subject to customs discretion within the framework of the Order.
Why Is This Legislation Important?
This Order is important because it provides a structured pathway for GST relief on imports—often crucial for entities importing regulated goods, conducting clinical research, or importing goods under specific institutional or public-interest arrangements. For businesses and institutions, the GST cost at importation can be significant; relief can therefore materially affect pricing, budgeting, and project feasibility.
From an enforcement and compliance standpoint, the Order is equally significant because it embeds customs-facing controls. The requirement to produce certificates/permits at the time of clearance (Section 3) and the ability to require security and impose additional conditions (Section 4) ensure that customs can verify eligibility and protect revenue. This means that a successful claim is not only about meeting substantive eligibility; it also depends on operational readiness and documentary discipline.
Finally, Section 5’s valuation clarification can prevent disputes and unintended GST exposure in mixed import scenarios. Practitioners should pay attention to how importers compute the “value of goods” for Schedule items and ensure that exempt imports are excluded from that valuation exercise, consistent with Section 5.
Related Legislation
- Goods and Services Tax Act (Cap. 117A) (authorising provisions: sections 24(1), (2) and (3) and 86(1))
- Customs Act (Cap. 70) (definitions and customs administration concepts)
- Medicines Act (Cap. 176) (definition of “medicinal product”)
- Health Products Act (Cap. 122D) (definition of “therapeutic product” and related regulatory framework)
- Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (definition of “Class 2 CTGT product”)
- Medicines (Clinical Trials) Regulations 2016 (definition of “regulated clinical trial”)
- Health Products (Clinical Trials) Regulations 2016 (definition of “regulated clinical trial”)
Source Documents
This article provides an overview of the Goods and Services Tax (Imports Relief) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.